- Report
- April 2022
- 119 Pages
Global
From €3456EUR$3,500USD£2,886GBP
- Report
- August 2023
- 80 Pages
Vietnam
From €1481EUR$1,500USD£1,237GBP
- Report
- August 2023
- 80 Pages
United States
From €1481EUR$1,500USD£1,237GBP
- Report
- August 2023
- 80 Pages
United Kingdom
From €1481EUR$1,500USD£1,237GBP
From €1481EUR$1,500USD£1,237GBP
- Report
- August 2023
- 80 Pages
South Korea
From €1481EUR$1,500USD£1,237GBP
- Report
- August 2023
- 80 Pages
Russia
From €1481EUR$1,500USD£1,237GBP
- Report
- August 2023
- 80 Pages
Poland
From €1481EUR$1,500USD£1,237GBP
- Report
- August 2023
- 80 Pages
Japan
From €1481EUR$1,500USD£1,237GBP
- Report
- August 2023
- 80 Pages
Ireland
From €1481EUR$1,500USD£1,237GBP
- Report
- August 2023
- 80 Pages
Germany
From €1481EUR$1,500USD£1,237GBP
- Report
- August 2023
- 80 Pages
France
From €1481EUR$1,500USD£1,237GBP
- Report
- August 2023
- 80 Pages
China
From €1481EUR$1,500USD£1,237GBP
- Report
- August 2023
- 80 Pages
Brazil
From €1481EUR$1,500USD£1,237GBP
- Report
- August 2023
- 80 Pages
Argentina
From €1481EUR$1,500USD£1,237GBP
- Report
- August 2023
- 100 Pages
Africa
From €1975EUR$2,000USD£1,649GBP
- Report
- August 2022
- 40 Pages
Argentina
From €1481EUR$1,500USD£1,237GBP
- Report
- August 2022
- 40 Pages
Poland
From €1481EUR$1,500USD£1,237GBP
- Report
- August 2022
- 40 Pages
Vietnam
From €1481EUR$1,500USD£1,237GBP
- Report
- August 2022
- 40 Pages
South Korea
From €1481EUR$1,500USD£1,237GBP
The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more